Education

• Ph.D., Pharmacy (The University of California at San Francisco, 1992)
• B.S., Pharmacy (The University of Texas at Austin, 1986)
• Postdoctoral Fellow, Pharmaceutics (University of California at San Francisco, 1993)

Academic Appointments/Professional Experience

• May 2000-Present. Associate Professor with tenure, Department of Pharmaceutics, Virginia Commonwealth University
• September 1993-2000. Assistant Professor, Department of Pharmaceutics, Virginia Commonwealth University
• September 1987-September 1989. Research Assistant, Department of Pharmaceutical Chemistry, University of California
• September 1986-September 1987. Teaching Assistant, Department of Pharmaceutical Chemistry, University of California

The publications search is performed on the National Library of Medicine's PubMed database. The search may be slow during high traffic hours, may return articles authored by another researcher with a similar name and may not always find all of a researcher's articles.

Publications

Books/Book Chapters

• Wu-Pong S, Rojanasakul Y, Editors: Biopharmaceutical Drug Design and Development, 2nd Edition, ISBN: 978-1-58829-716-7, Humana Press, Totowa, NJ, 2008.
• Wu-Pong S: “An Overview of Biotechnology Overview”. In: Biopharmaceutical Drug Design and Development. 2nd Volume (Eds Rojanasakul Y). Humana Press, Totawa, NJ, ISBN: 978-1-58829-716-7, pp 1-20, 2008.
• Wu-Pong S: “Treatment Options”. In: Biopharmaceutical Drug Design and Development. 2nd Volume (Eds Rojanasakul Y). Humana Press, Totawa, NJ, ISBN: 978-1-58829-716-7, pp 51-68, 2008.
• Wu-Pong S and Lysik M: “Oligonucleotides and Ribozymes”. In: Biopharmaceutical Drug Design and Development. 2nd Volume (Eds Rojanasakul Y). Humana Press, Totawa, NJ, ISBN: 978-1-58829-716-7, pp 143-186, 2008.
• Shargel L, Wu-Pong S, Yu Andrew, editors: Applied Biopharmaceutics and Pharmacokinetics, 5th edition, McGraw Hill Medical Publishing, 2005, ISBN # 0071375503.
Recent Publications

• S. Wu-Pong. "An alternate hypothesis for oligonucleotide cellular uptake: a new look at the literature". Adv.Drug Del.Rev.;44:59-70, (2000).
• W.C. Broaddus, S.S. Prabhu, S. Wu-Pong, G.T. Gillies and H. Fillmore. "Design and delivery of antisense oligonucleotide strategies in the central nervous system". Antisense technology. Phillips, M. Ian, Ed., San Diego, CA: Academic Press, Methods in Enzymology 314;121-135, (2000).
• S. Wu-Pong, V. Livesay, B. Dvorchik and W.H. Barr. "Oligonucleotide transport in rat and human intestine Using Chamber model". Biopharm. Drug Dispos.;20(9):411-6, (1999).
• R. Tam, S. Wu-Pong, B. Pai, C. Lim, A. Chan, D.F. Thomas, T. Milovanovic, and J. Bard. "Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages, Antisense Nucl". Acid Drug Del.;9:289-300, (1999).
• M.A.E. Jarvis, S. Wu-Pong, J.S. Kniseley, S.H. Schnoll. "Alterations in methadone metabolism during late pregnancy". J.Addict.Dis.; 18(4): 51-61, (1999).